Today, the Dutch Consumers' Association presented 15,000 signatures to Health Minister Ab Klink, demanding a ban on symptom advertising by pharmaceutical companies.
Direct advertising of medicines is already prohibited in the Netherlands. In its place, many pharma firms use symptom advertising—promoting awareness of common ailments in ads to boost demand for related treatments.
The campaign was sparked by a Radar broadcast exposing how these tactics urge consumers to consult doctors for minor issues, such as fungal nail infections.
The Association argues that time and resources spent on such trivial complaints should prioritize patients with serious conditions.
